About the Program

Message From the Program Director

Joseph Jankovic, M.D. (320x240)
Joseph Jankovic, M.D., Professor of Neurology, Distinguished Chair in Movement Disorders, Director of Parkinson's Disease Center and Movement Disorders Clinic

The Movement Disorders Fellowship program in the Department of Neurology at Baylor College of Medicine, founded by Dr. Joseph Jankovic in 1977, is an integral part of the Parkinson's Disease Center and Movement Disorders Clinic.

The MDFTP has been certified by the Texas State Board of Medical Examiners as a two-year clinical fellowship program. Fellows who complete the two-year fellowship will receive a diploma, signed by Dr. Jankovic and Baylor officials. During the third (optional) year, the fellow may continue the training as a clinical fellow or he/she may elect to participate in basic research and acquire skills in various laboratory techniques necessary for the study of biologic, genetic and biochemical mechanisms of neurodegenerative disorders. Fellows who obtain a Texas medical license and become appropriately credentialed become eligible for a faculty appointment.

We are a large tertiary referral center for patients with all types of movement disorders, including an active DBS and botulinum toxin clinical practice, and multiple opportunities for clinical research and publications.

There are four movement disorder fellows. Career guidance and employment opportunities are discussed via individual mentoring sessions.

Parkinson's Disease Center and Movement Disorders Clinic

Fellows obtain one-on-one mentoring from PDCMDC faculty and training in the diagnosis and treatment of a large variety of hypokinetic and hyperkinetic movement disorders. The trainees also develop skills in the administration of botulinum toxin injections, in evaluating patients before and after deep brain stimulation, and other therapeutic interventions.

The PDCMDC also provides a setting for clinical research and a two-year fellowship program, which focuses on the recognition, pathophysiology and treatment of movement disorders, including development of skills in botulinum toxin injections and deep brain stimulation.

The fellows have an easy, direct and frequent access to the PDCMDC faculty and other clinical and basic science researchers and collaborators. By developing and pursuing mentor-guided projects and adhering to the Good Clinical Practice standards, they acquire knowledge about study design, conduct of clinical trials, data collection and analysis, and scientific writing. The fellows participate in weekly video rounds and neurogenetic workshops and monthly journal clubs and deep brain stimulation conferences. They critically evaluate literature and present their findings at lectures, by scientific articles, and other scientific and educational conferences. They are also involved in new and ongoing clinical research trials and other PDCMDC studies in experimental therapeutics, pharmacology, physiology, epidemiology, and genetics of disorders of movement and motor control. Fellows are encouraged to present abstracts at various national and international meetings and to be the first authors on publications in peer-reviewed journals.

The faculty of the PDCMDC has published nearly 1,000 articles, chapters, and other publications. Dr. Jankovic has co-edited over 50 books and volumes, including several standard textbooks such as "Neurology in Clinical Practice", "Parkinson's Disease and Movement Disorders" (along with a video atlas), and "Principles and Practice of Movement Disorders", based on an annual comprehensive course on movement disorders. All new fellows are invited to this course offered each summer in Aspen, Colo.